September 21, 2021

In this installment of The Legal Prescription with Pharmacy Times, Ned Milenkovich, chair of Much’s Health Care group, continues to shed light on HR 841 – the Hemp Bill. Ned discusses how the FDA's stance on CBD has affected small businesses and consumers, talks about the current marketplace, and highlights the benefits that pharmacists’ involvement could bring.

This article contains material of general interest and should not be construed as legal advice or a legal opinion on any specific facts or circumstances. Under applicable rules of professional conduct, this content may be regarded as attorney advertising.